Ardelyx Ownership

ARDX Stock  USD 5.47  0.05  0.92%   
Ardelyx holds a total of 238.36 Million outstanding shares. Over half of Ardelyx's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2013-03-31
Previous Quarter
236 M
Current Value
235 M
Avarage Shares Outstanding
85.7 M
Quarterly Volatility
75.3 M
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Ardelyx in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Ardelyx, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ardelyx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Ardelyx Stock please use our How to Invest in Ardelyx guide.

Ardelyx Stock Ownership Analysis

About 64.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.17. Ardelyx had not issued any dividends in recent years. Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. Ardelyx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 86 people. For more info on Ardelyx please contact Michael Raab at 510 745 1700 or go to https://www.ardelyx.com.
Besides selling stocks to institutional investors, Ardelyx also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Ardelyx's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Ardelyx's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Ardelyx Quarterly Liabilities And Stockholders Equity

435.75 Million

Ardelyx Insider Trades History

Roughly 2.0% of Ardelyx are currently held by insiders. Unlike Ardelyx's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Ardelyx's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Ardelyx's insider trades
 
Yuan Drop
 
Covid

Ardelyx Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Ardelyx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ardelyx backward and forwards among themselves. Ardelyx's institutional investor refers to the entity that pools money to purchase Ardelyx's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Goldman Sachs Group Inc2024-12-31
2.2 M
Northern Trust Corp2024-12-31
2.2 M
Oracle Investment Management Inc2024-12-31
2.1 M
Charles Schwab Investment Management Inc2024-12-31
M
Bank Of America Corp2024-12-31
1.9 M
Two Seas Capital Lp2024-12-31
1.9 M
Rubric Capital Management Lp2024-12-31
1.7 M
Redmile Group, Llc2024-12-31
1.6 M
D. E. Shaw & Co Lp2024-12-31
1.5 M
Hhg Plc2024-12-31
24.4 M
Blackrock Inc2024-12-31
18.5 M
Note, although Ardelyx's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ardelyx Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ardelyx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ardelyx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ardelyx insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Ardelyx Outstanding Bonds

Ardelyx issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ardelyx uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ardelyx bonds can be classified according to their maturity, which is the date when Ardelyx has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Ardelyx Corporate Filings

F4
7th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
20th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
14th of February 2025
Other Reports
ViewVerify
5th of February 2025
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Ardelyx Stock Analysis

When running Ardelyx's price analysis, check to measure Ardelyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ardelyx is operating at the current time. Most of Ardelyx's value examination focuses on studying past and present price action to predict the probability of Ardelyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ardelyx's price. Additionally, you may evaluate how the addition of Ardelyx to your portfolios can decrease your overall portfolio volatility.